Related Experiment Video
Updated: Jul 26, 2025
08:15
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
8.6K
Humanized Mouse Model of HIV Infection
D S Leontyev1, D V Glazkova2, O A Bezborodova3
1Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical-Biological Agency of Russia, Moscow, Russia. danila.leontyev@gmail.com.
Bulletin of Experimental Biology and Medicine
|June 20, 2023
Summary
Researchers developed a humanized mouse model in Russia for HIV drug testing. These mice successfully replicated HIV, showing potential for preclinical studies.
Area of Science:
- Immunology
- Virology
- Preclinical drug development
Background:
- Developing new HIV treatments requires effective animal models.
- Humanized mice are crucial for HIV research but unavailable in Russia.
Purpose of the Study:
- To establish a humanized mouse model in Russia for HIV research.
- To assess the efficacy of this model in supporting HIV replication.
Main Methods:
- Humanizing immunodeficient NSG mice using human hematopoietic stem cells.
- Characterizing chimerism and lymphocyte repopulation.
- Inoculating humanized mice with HIV-1 and monitoring viremia.
Main Results:
- Successful humanization of mice with high chimerism.
- Repopulation of human lymphocytes essential for HIV replication.
- Stable HIV-1 viremia confirmed by viral RNA and proviral DNA detection.
Conclusions:
- The developed humanized mouse model supports HIV replication.
- This model is suitable for preclinical testing of HIV therapeutics in Russia.
